• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向细胞因子和趋化因子信号通路以增强结直肠癌的化疗敏感性

Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer.

作者信息

Li Shisen, Xie Mianjiao, Du Yongtao, Tan Zhaobang

机构信息

Department of Digestive Surgery, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710032, China.

Department of Experimental Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, 710032, China.

出版信息

Cell Commun Signal. 2025 Aug 12;23(1):369. doi: 10.1186/s12964-025-02235-7.

DOI:10.1186/s12964-025-02235-7
PMID:40796863
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12341088/
Abstract

Chemo-resistance is one of the main obstacles in the treatment of colorectal cancer. Many studies have been performed to identify the mechanisms associated with chemo-resistance in colorectal cancer cells, and it has been found that increasing the activity of ABC family transporters, enhancing DNA repair, weakening apoptosis, strengthening stemness, and EMT are among the most important of these mechanisms. Inflammation and cytokines have been linked to colorectal cancer, and there is even a type of colorectal cancer that is caused by chronic inflammation in patients with inflammatory bowel disease. However, the association between cytokines and chemo-resistance in colorectal cancer cells is not yet clear. Various studies have shown that chemotherapy drugs, by affecting the tumor microenvironment, can enhance the recruitment of some immune cells and the production of some cytokines. These cytokines have a variety of effects on various chemo-resistance mechanisms in colorectal cancer cells. Some of them can strengthen chemo-resistance and others weaken chemo-resistance. IL-6, TNFα, IFN, IL1, IL8, IL-17, IL-10, and IL-22 are among the most important cytokines whose effects on chemo-resistance mechanisms in colorectal cancer cells are known. In this article, we will have a comprehensive overview of the effects of these cytokines on chemo-resistance mechanisms in colorectal cancer cells.

摘要

化疗耐药是结直肠癌治疗中的主要障碍之一。已经进行了许多研究来确定与结直肠癌细胞化疗耐药相关的机制,并且发现增加ABC家族转运蛋白的活性、增强DNA修复、减弱凋亡、强化干性以及上皮-间质转化是这些机制中最重要的部分。炎症和细胞因子与结直肠癌有关,甚至有一种结直肠癌是由炎症性肠病患者的慢性炎症引起的。然而,细胞因子与结直肠癌细胞化疗耐药之间的关联尚不清楚。各种研究表明,化疗药物通过影响肿瘤微环境,可以增强一些免疫细胞的募集和一些细胞因子的产生。这些细胞因子对结直肠癌细胞的各种化疗耐药机制有多种影响。其中一些可以增强化疗耐药性,而另一些则减弱化疗耐药性。白细胞介素-6(IL-6)、肿瘤坏死因子α(TNFα)、干扰素(IFN)、白细胞介素-1(IL1)、白细胞介素-8(IL8)、白细胞介素-17(IL-17)、白细胞介素-10(IL-10)和白细胞介素-22(IL-22)是已知对结直肠癌细胞化疗耐药机制有影响的最重要的细胞因子。在本文中,我们将全面概述这些细胞因子对结直肠癌细胞化疗耐药机制的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ee/12341088/abd35430ec63/12964_2025_2235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ee/12341088/abd35430ec63/12964_2025_2235_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/44ee/12341088/abd35430ec63/12964_2025_2235_Fig1_HTML.jpg

相似文献

1
Targeting cytokine and chemokine signaling pathways for enhancing chemo-sensitivity in colorectal cancer.靶向细胞因子和趋化因子信号通路以增强结直肠癌的化疗敏感性
Cell Commun Signal. 2025 Aug 12;23(1):369. doi: 10.1186/s12964-025-02235-7.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
7
Transarterial (chemo)embolisation versus systemic chemotherapy for colorectal cancer liver metastases.经动脉(化疗)栓塞与全身化疗治疗结直肠癌肝转移。
Cochrane Database Syst Rev. 2024 Aug 9;8(8):CD012757. doi: 10.1002/14651858.CD012757.pub2.
8
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
9
A systematic overview of chemotherapy effects in colorectal cancer.结直肠癌化疗效果的系统综述。
Acta Oncol. 2001;40(2-3):282-308. doi: 10.1080/02841860151116367.
10
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织(EORTC)癌症贫血患者促红细胞生成蛋白使用指南:2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.

本文引用的文献

1
Cytokines in cancer.癌症中的细胞因子
Cancer Cell. 2025 Jan 13;43(1):15-35. doi: 10.1016/j.ccell.2024.11.011. Epub 2024 Dec 12.
2
Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments.结直肠癌:癌变、诊断的全面综述及分类治疗的新策略。
Cancer Metastasis Rev. 2024 Jun;43(2):729-753. doi: 10.1007/s10555-023-10158-3. Epub 2023 Dec 19.
3
Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
细胞因子和趋化因子诱导的炎症性结直肠肿瘤微环境:靶向治疗的新途径。
Cancer Commun (Lond). 2022 Aug;42(8):689-715. doi: 10.1002/cac2.12295. Epub 2022 Jul 5.
4
From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?从炎症性肠病到结直肠癌:微小RNA起什么作用?
Cancer Cell Int. 2022 Apr 11;22(1):146. doi: 10.1186/s12935-022-02557-3.
5
IL-10 contributes to gemcitabine resistance in extranodal NK/T-cell lymphoma cells via ABCC4.白细胞介素-10通过ABCC4促进结外NK/T细胞淋巴瘤细胞对吉西他滨的耐药性。
Invest New Drugs. 2022 Jun;40(3):537-545. doi: 10.1007/s10637-022-01224-8. Epub 2022 Feb 28.
6
Immunotherapy for Colorectal Cancer: Mechanisms and Predictive Biomarkers.结直肠癌的免疫治疗:机制与预测生物标志物
Cancers (Basel). 2022 Feb 17;14(4):1028. doi: 10.3390/cancers14041028.
7
Chemotherapy-induced cytokines and prognostic gene signatures vary across breast and colorectal cancer.化疗诱导的细胞因子和预后基因特征在乳腺癌和结直肠癌中各不相同。
Am J Cancer Res. 2021 Dec 15;11(12):6086-6106. eCollection 2021.
8
A novel HDAC1/2 inhibitor suppresses colorectal cancer through apoptosis induction and cell cycle regulation.一种新型的 HDAC1/2 抑制剂通过诱导细胞凋亡和细胞周期调控抑制结直肠癌。
Chem Biol Interact. 2022 Jan 25;352:109778. doi: 10.1016/j.cbi.2021.109778. Epub 2021 Dec 17.
9
Vesicular IFN-γ as a cooperative attacker to enhance anti-cancer effect of 5-fluorouracil via thymidine phosphorylase upregulation and tumor microenvironment normalization.囊泡 IFN-γ 作为协同攻击物,通过上调胸苷磷酸化酶和肿瘤微环境正常化增强 5-氟尿嘧啶的抗癌作用。
Nanomedicine. 2022 Feb;40:102501. doi: 10.1016/j.nano.2021.102501. Epub 2021 Nov 26.
10
Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-B/BCL-2 Signaling Pathway In Vitro and In Vivo.Nrf3通过NF-κB/BCL-2信号通路在体外和体内促进结肠癌细胞对5-氟尿嘧啶的耐药性。
J Oncol. 2021 Nov 9;2021:9355555. doi: 10.1155/2021/9355555. eCollection 2021.